SCHEMBL19610484

SCHEMBL19610484

CC(C)c1cc(-c2cc(C(C)C)c(OCc3ccccc3)c(C(C)C)c2)cc(C(C)C)c1CC(=O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLRA1 P23415 2/20 0.62
LMNA P02545 1/20 0.43
HPGD P15428 1/20 0.43
SRD5A2 P31213 1/20 0.43
FFAR1 O14842 3/20 0.42
PPARD Q03181 1/20 0.42
NR1H4 Q96RI1 1/20 0.42
THRA P10827 1/20 0.42
THRB P10828 1/20 0.42
PTPN1 P18031 1/20 0.41
PTGER1 P34995 2/20 0.41
PTGER4 P35408 2/20 0.41
PTGER3 P43115 2/20 0.41
PTGER2 P43116 2/20 0.41
CFD P00746 1/20 0.41
F11 P03951 1/20 0.41
TPSB2 P20231 1/20 0.41
MCL1 Q07820 2/20 0.40
PTGDR2 Q9Y5Y4 1/20 0.40
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19610490 0.80 CA1 (0.46) SRD5A2THRATHRBKDM4EMEN1
SCHEMBL16860678 0.79 GLRA1 (0.79) GLRA1LMNAHPGDSRD5A2KDM4E
SCHEMBL16860746 0.77 GLRA1 (1.00) GLRA1LMNAHPGDTHRATHRB
SCHEMBL6036279 0.76 GLRA1 (0.54) GLRA1LMNAHPGDFFAR1THRA
SCHEMBL20681207 0.75 ACMSD (0.44) HPGDPTGDR2KDM4E
SCHEMBL30791048 0.75 ACMSD (0.44) HPGDPTGDR2KDM4E
SCHEMBL16785954 0.75 GLRA1 (0.63) GLRA1LMNAHPGDMEN1KMT2A
SCHEMBL4897760 0.74 THRB (0.54) GLRA1FFAR1THRATHRB
SCHEMBL25138966 0.74 PTGER1 (0.51) GLRA1PTGER1PTGER4PTGER3PTGER2
SCHEMBL31419968 0.74 GLRA1 (0.62) GLRA1LMNAHPGDTHRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3246022-A1 THE USE OF DIPHENOL IN PREPARATION OF MEDICINES FOR PREVENTION AND TREATMENT OF CEREBRAL ISCHEMIA Xi'an Libang Pharmaceutical Co., Ltd (CN) 2017-11-22 EP claimed
US-20200179302-A1 USE OF DIPHENOL IN PREPARATION OF MEDICINES FOR PREVENTION AND TREATMENT OF CEREBRAL ISCHEMIA XI'AN LIBANG PHARMACEUTICAL CO., LTD (CN) 2020-06-11 US disclosed
US-10329243-B2 Biphenyl derivative and uses thereof XI'AN LIBANG PHARMACEUTICAL CO., LTD (CN) 2019-06-25 US disclosed
US-20180185299-A1 THE USE OF DIPHENOL IN PREPARATION OF MEDICINES FOR PREVENTION AND TREATMENT OF CEREBRAL ISCHEMIA XI'AN LIBANG PHARMACEUTICAL CO., LTD (CN) 2018-07-05 US disclosed
US-20180141895-A1 DIPHENYL DERIVATIVE AND USES THEREOF XI'AN LIBANG PHARMACEUTICAL CO., LTD (CN) 2018-05-24 US disclosed
EP-3246022-A1 THE USE OF DIPHENOL IN PREPARATION OF MEDICINES FOR PREVENTION AND TREATMENT OF CEREBRAL ISCHEMIA Xi'an Libang Pharmaceutical Co., Ltd (CN) 2017-11-22 EP disclosed
EP-3246304-A2 DIPHENYL DERIVATIVE AND USES THEREOF Xi'an Libang Pharmaceutical Co., Ltd (CN) 2017-11-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200179302-A1 USE OF DIPHENOL IN PREPARATION OF MEDICINES FOR PREVENTION AND TREATMENT OF CEREBRAL ISCHEMIA PTGER3, PTGES3, CYP24A1 GLRA1 3133/4885LMNA 1953/4885HPGD 161/4885
US-10329243-B2 Biphenyl derivative and uses thereof PPARD, PCSK9, UGT2B7 GLRA1 4174/4885LMNA 1295/4885HPGD 1580/4885
US-20180141895-A1 DIPHENYL DERIVATIVE AND USES THEREOF PPARD, DPP3, DPP7 GLRA1 4599/4885LMNA 1537/4885HPGD 804/4885
US-20180185299-A1 THE USE OF DIPHENOL IN PREPARATION OF MEDICINES FOR PREVENTION AND TREATMENT OF CEREBRAL ISCHEMIA PTGER3, CYP24A1, PTGES3 GLRA1 3356/4885LMNA 1690/4885HPGD 154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.